Proposed Data Collection Submitted for Public Comment and Recommendations, 38098-38100 [2021-15228]
Download as PDF
<![CDATA[
38098
Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices
lotter on DSK11XQN23PROD with NOTICES1
evolving COVID–19 vaccine
development and regulatory processes.
The Secretary of Health and Human
Services has determined that COVID–19
is a Public Health Emergency. A notice
of this ACIP meeting has also been
posted on CDC’s ACIP website at: https://
www.cdc.gov/vaccines/acip/.
In addition, CDC has sent notice of this
ACIP meeting by email to those who
subscribe to receive email updates about
ACIP.
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on COVID–19
vaccine safety. Agenda items are subject
to change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
VerDate Sep<11>2014
18:23 Jul 16, 2021
Jkt 253001
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: Written
comments must be received on or before
July 22, 2021.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the July 22, 2021,
ACIP meeting must submit a request at
https://www.cdc.gov/vaccines/acip/
meetings/ no later than 11:59 p.m., EDT,
July 20, 2021, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by 12:00 p.m., EDT, July 21, 2021. To
accommodate the significant interest in
participation in the oral public
comment session of ACIP meetings,
each speaker will be limited to 3
minutes, and each speaker may only
speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–15322 Filed 7–14–21; 4:15 pm]
BILLING CODE 4163–18–P
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21GO; Docket No. CDC–2021–
0068]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Evaluating the use of EHMRs in
health settings to improve
organizational implementation and
worker adoption during and after the
COVID–19 pandemic. NIOSH proposes
using surveys and interviews to
understand how elastomeric half mask
respirators (EHMRs) are being perceived
and used by healthcare and first
responder settings during the COVID–19
pandemic.
DATES: CDC must receive written
comments on or before September 17,
2021.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0068 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
ADDRESSES:
E:\FR\FM\19JYN1.SGM
19JYN1
38099
Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluating the use of EHMRs in
health settings to improve
organizational implementation and
worker adoption during and after the
COVID–19 pandemic—New—National
that posted in September 2020, titled,
‘‘A National Elastomeric Half Mask
Respirator (EHMR) Strategy for Use in
Healthcare Settings During an Infectious
Disease Outbreak/Pandemic.’’—Vol. 85,
No. 178. The announcement requested
information regarding the deployment
and use of EHMRs in healthcare settings
and first responder organizations during
the COVID–19 crisis.
This proposed study involves
conducting surveys and interviews.
Individual workers who receive EHMRs
from their organization will have the
option to voluntarily participate in a
pre-/post-survey. Voluntary data
collection at the organizational level
with members of management will
occur using an interview format that
follows a semi-structured approach to
capture information throughout the
duration of NIOSH’s research study.
Individual workers (via surveys) and
organization management (via
interviews) will participate in data
collection activities over a period of
approximately 4–9 months to assess
perceptions, knowledge, attitudes, and
experiences using EHMRs as well as
best practices for adoption and
implementation of EHMRs at their
organizations. Individuals who are
asked to respond are those who notified
NIOSH of their interest of participating
in the study. Respondents are expected
to include a variety of job types
including industrial hygienists,
occupational health professionals,
infection control professionals,
physicians, nurse practitioners, nurses,
infection preventionists, fire department
chiefs, battalion chiefs, sheriffs, shift
supervisors, firefighters, police officers,
and paramedics.
A multi-site approach is necessary to
answer and further validate findings
related to the study objectives. By
conducting several studies at healthcare
and first responder locations, NIOSH
researchers can make the case for
research progression, which enhances
the reliability and validity of any
revised guidance.
NIOSH requests approval for a total of
42,877 estimated burden hours. There
are no costs to respondents other than
their time to participate.
Institute of Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC/NIOSH is requesting approval of
a new data collection for a period of two
years under the project titled
‘‘Evaluating the use of EHMRs in health
settings to improve organizational
implementation and worker adoption
during and after the COVID–19
pandemic.’’ The data collection
activities were initiated under the
Public Health Emergency PRA waiver.
NIOSH has the responsibility to conduct
research relating to innovative methods,
techniques, and approaches dealing
with occupational safety and health
problems. Additionally, OSHA’s
Emergency Temporary Standard (ETS)
for COVID–19 in Healthcare released in
June 2021 (29 CFR 1910, Subpart U) is
facilitating the need for this work.
Finally, during the nationwide shortage
of filtering facepiece respirators (FFRs),
the Food and Drug Administration
(FDA) issued an emergency use
authorization (EUA), allowing the use of
all NIOSH-approved respiratory
protective devices in healthcare settings
during the pandemic—of which
elastomeric half mask respirators
(EHMRs) were included (85 FR 17335,
March 27, 2020). This EUA was
provided for alternative FFR use in
healthcare settings to prevent wearer
(i.e., worker) exposure to airborne
particulates because of the COVID–19
pandemic and the life-threatening
illness it can cause (FDA, 2020).
Currently, organizations are being
confronted with the use of new
respiratory protection and questions on
how to best support its implementation
during the pandemic. To that end, the
purpose of this demonstration research
study is to assess the integration of
EHMRs in various healthcare and first
responder settings and subsequently
update and enhance EHMR best
practices and implementation
guidelines to encourage adoption and
consequently, reduce PPE supply
shortages during the current and future
pandemics.
This project is supported through a
NIOSH Federal Register Notice (FRN)
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Organizational manager/POC .......................
Informed Consent .................
Time 1 Interview ...................
Time 2 Interview ...................
Time 3 Interview ...................
VerDate Sep<11>2014
18:23 Jul 16, 2021
Jkt 253001
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
150
150
150
150
E:\FR\FM\19JYN1.SGM
3
1
1
1
19JYN1
Average
burden per
response
(in hours)
5/60
45/60
45/60
45/60
Total burden
hours
38
113
113
113
38100
Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)
Total burden
hours
Form name
Individual Healthcare/First Responder .........
Informed Consent .................
Baseline Survey ....................
Follow-up Survey ..................
51,000
51,000
51,000
2
1
1
5/60
20/60
20/60
8,500
17,000
17,000
Total .......................................................
...............................................
........................
........................
........................
42,877
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–15228 Filed 7–16–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1244; Docket No. CDC–2021–
0063]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on an
Extension of a previously approved
information collection project titled
Assessment of Occupational Injury
among Fire Fighters Using a Followback Survey. The purpose of this project
is to collect follow-back telephone
interview data from injured and
exposed firefighters treated in
emergency departments (EDs) and
produce a descriptive summary of these
injuries and exposures.
DATES: CDC must receive written
comments on or before September 17,
2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0063 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Number of
respondents
Type of respondent
VerDate Sep<11>2014
18:23 Jul 16, 2021
Jkt 253001
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Assessment of Occupational Injury
among Fire Fighters Using a Followback Survey (OMB Control No. 0920–
1244)—Extension—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Studies have reported that firefighters
have high rates of non-fatal injuries and
illnesses as compared to the general
worker population. As firefighters
perform critical public safety activities
and protect the safety and health of the
public, it follows that understanding
and preventing injuries and exposures
among firefighters will have a benefit
reaching beyond the workers to the
public.
As mandated in the Occupational
Safety and Health Act of 1970 (Pub. L.
91–596), the mission of NIOSH is to
conduct research and investigations on
occupational safety and health. Related
to this mission, the purpose of this
project is to conduct research that will
provide a detailed description of nonfatal occupational injuries and
exposures incurred by firefighters. This
information will offer detailed insight
into events that lead to the largest
number of nonfatal injuries and
exposures among firefighters. The
project will use two related data
sources. The first source is data
abstracted from medical records of
firefighters treated in a nationally
stratified sample of emergency
E:\FR\FM\19JYN1.SGM
19JYN1
]]>Agencies
[Federal Register Volume 86, Number 135 (Monday, July 19, 2021)]
[Notices]
[Pages 38098-38100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15228]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-21GO; Docket No. CDC-2021-0068]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Evaluating the use of EHMRs in
health settings to improve organizational implementation and worker
adoption during and after the COVID-19 pandemic. NIOSH proposes using
surveys and interviews to understand how elastomeric half mask
respirators (EHMRs) are being perceived and used by healthcare and
first responder settings during the COVID-19 pandemic.
DATES: CDC must receive written comments on or before September 17,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0068 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road,
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger,
[[Page 38099]]
Information Collection Review Office, Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS-D74, Atlanta, Georgia 30329;
phone: 404-639-7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Evaluating the use of EHMRs in health settings to improve
organizational implementation and worker adoption during and after the
COVID-19 pandemic--New--National Institute of Occupational Safety and
Health (NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC/NIOSH is requesting approval of a new data collection for a
period of two years under the project titled ``Evaluating the use of
EHMRs in health settings to improve organizational implementation and
worker adoption during and after the COVID-19 pandemic.'' The data
collection activities were initiated under the Public Health Emergency
PRA waiver. NIOSH has the responsibility to conduct research relating
to innovative methods, techniques, and approaches dealing with
occupational safety and health problems. Additionally, OSHA's Emergency
Temporary Standard (ETS) for COVID-19 in Healthcare released in June
2021 (29 CFR 1910, Subpart U) is facilitating the need for this work.
Finally, during the nationwide shortage of filtering facepiece
respirators (FFRs), the Food and Drug Administration (FDA) issued an
emergency use authorization (EUA), allowing the use of all NIOSH-
approved respiratory protective devices in healthcare settings during
the pandemic--of which elastomeric half mask respirators (EHMRs) were
included (85 FR 17335, March 27, 2020). This EUA was provided for
alternative FFR use in healthcare settings to prevent wearer (i.e.,
worker) exposure to airborne particulates because of the COVID-19
pandemic and the life-threatening illness it can cause (FDA, 2020).
Currently, organizations are being confronted with the use of new
respiratory protection and questions on how to best support its
implementation during the pandemic. To that end, the purpose of this
demonstration research study is to assess the integration of EHMRs in
various healthcare and first responder settings and subsequently update
and enhance EHMR best practices and implementation guidelines to
encourage adoption and consequently, reduce PPE supply shortages during
the current and future pandemics.
This project is supported through a NIOSH Federal Register Notice
(FRN) that posted in September 2020, titled, ``A National Elastomeric
Half Mask Respirator (EHMR) Strategy for Use in Healthcare Settings
During an Infectious Disease Outbreak/Pandemic.''--Vol. 85, No. 178.
The announcement requested information regarding the deployment and use
of EHMRs in healthcare settings and first responder organizations
during the COVID-19 crisis.
This proposed study involves conducting surveys and interviews.
Individual workers who receive EHMRs from their organization will have
the option to voluntarily participate in a pre-/post-survey. Voluntary
data collection at the organizational level with members of management
will occur using an interview format that follows a semi-structured
approach to capture information throughout the duration of NIOSH's
research study. Individual workers (via surveys) and organization
management (via interviews) will participate in data collection
activities over a period of approximately 4-9 months to assess
perceptions, knowledge, attitudes, and experiences using EHMRs as well
as best practices for adoption and implementation of EHMRs at their
organizations. Individuals who are asked to respond are those who
notified NIOSH of their interest of participating in the study.
Respondents are expected to include a variety of job types including
industrial hygienists, occupational health professionals, infection
control professionals, physicians, nurse practitioners, nurses,
infection preventionists, fire department chiefs, battalion chiefs,
sheriffs, shift supervisors, firefighters, police officers, and
paramedics.
A multi-site approach is necessary to answer and further validate
findings related to the study objectives. By conducting several studies
at healthcare and first responder locations, NIOSH researchers can make
the case for research progression, which enhances the reliability and
validity of any revised guidance.
NIOSH requests approval for a total of 42,877 estimated burden
hours. There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Organizational manager/POC.... Informed Consent 150 3 5/60 38
Time 1 Interview 150 1 45/60 113
Time 2 Interview 150 1 45/60 113
Time 3 Interview 150 1 45/60 113
[[Page 38100]]
Individual Healthcare/First Informed Consent 51,000 2 5/60 8,500
Responder.
Baseline Survey. 51,000 1 20/60 17,000
Follow-up Survey 51,000 1 20/60 17,000
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 42,877
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15228 Filed 7-16-21; 8:45 am]
BILLING CODE 4163-18-P
